These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 17647026)

  • 21. Independent regulation of renin-angiotensin-aldosterone system in the kidney.
    Nishiyama A; Kobori H
    Clin Exp Nephrol; 2018 Dec; 22(6):1231-1239. PubMed ID: 29600408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation induced by podocyte injury.
    Okabe M; Miyazaki Y; Niimura F; Pastan I; Nishiyama A; Yokoo T; Ichikawa I; Matsusaka T
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F932-7. PubMed ID: 25673808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.
    Ma LJ; Yang H; Gaspert A; Carlesso G; Barty MM; Davidson JM; Sheppard D; Fogo AB
    Am J Pathol; 2003 Oct; 163(4):1261-73. PubMed ID: 14507636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.
    Krämer S; Loof T; Martini S; Rückert M; Wang Y; Böhler T; Shimizu F; Kawachi H; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F359-68. PubMed ID: 15769934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteinuria and its consequences in renal disease.
    Schieppati A; Remuzzi G
    Acta Paediatr Suppl; 2003 Dec; 92(443):9-13; discussion 5. PubMed ID: 14989459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New concept of chronic kidney disease and blockade of renin-angiotensin system].
    Takeda T; Gejyo F
    Nihon Rinsho; 2007 Sep; 65(9):1727-33. PubMed ID: 17877002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathways to nephron loss starting from glomerular diseases-insights from animal models.
    Kriz W; LeHir M
    Kidney Int; 2005 Feb; 67(2):404-19. PubMed ID: 15673288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.
    Abbate M; Zoja C; Morigi M; Rottoli D; Angioletti S; Tomasoni S; Zanchi C; Longaretti L; Donadelli R; Remuzzi G
    Am J Pathol; 2002 Dec; 161(6):2179-93. PubMed ID: 12466133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.
    Warady BA; Abraham AG; Schwartz GJ; Wong CS; Muñoz A; Betoko A; Mitsnefes M; Kaskel F; Greenbaum LA; Mak RH; Flynn J; Moxey-Mims MM; Furth S
    Am J Kidney Dis; 2015 Jun; 65(6):878-88. PubMed ID: 25799137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
    Kobori H; Nangaku M; Navar LG; Nishiyama A
    Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The intrarenal renin-angiotensin system: a paracrine system for the local control of renal function separate from the systemic axis.
    Harris RC; Cheng HF
    Exp Nephrol; 1996; 4 Suppl 1():2-7. PubMed ID: 9001891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Abnormality of renin-angiotensin system in podocyte dysfunction in diabetic kidney disease].
    Shao DC; Lu LM
    Sheng Li Ke Xue Jin Zhan; 2011 Aug; 42(4):246-50. PubMed ID: 22066414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research into the glomerular podocyte--is it relevant to diabetic nephropathy?
    White KE
    Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
    Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
    Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hypertension on the progression of chronic renal failure in children.
    Soergel M; Schaefer F
    Am J Hypertens; 2002 Feb; 15(2 Pt 2):53S-56S. PubMed ID: 11866231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spread of glomerular to tubulointerstitial disease with a focus on proteinuria.
    Theilig F
    Ann Anat; 2010 May; 192(3):125-32. PubMed ID: 20400279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Cruz DN; Schmidt-Ott KM; Vescovo G; House AA; Kellum JA; Ronco C; McCullough PA
    Contrib Nephrol; 2013; 182():117-36. PubMed ID: 23689659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.